Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples